These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 17880531
21. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells. Flaiz C, Utermark T, Parkinson DB, Poetsch A, Hanemann CO. Glia; 2008 Apr; 56(5):506-15. PubMed ID: 18240308 [Abstract] [Full Text] [Related]
22. The area composita of adhering junctions connecting heart muscle cells of vertebrates. V. The importance of plakophilin-2 demonstrated by small interference RNA-mediated knockdown in cultured rat cardiomyocytes. Pieperhoff S, Schumacher H, Franke WW. Eur J Cell Biol; 2008 Jul; 87(7):399-411. PubMed ID: 18261826 [Abstract] [Full Text] [Related]
23. Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Sobolik-Delmaire T, Katafiasz D, Keim SA, Mahoney MG, Wahl JK. Cell Commun Adhes; 2007 Jul; 14(2-3):99-109. PubMed ID: 17668353 [Abstract] [Full Text] [Related]
25. Cell-matrix talks: effects on differentiation of hepatocellular carcinoma. Wu XZ, Chen D. Minerva Gastroenterol Dietol; 2006 Dec; 52(4):407-13. PubMed ID: 17108870 [Abstract] [Full Text] [Related]
26. γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown. Wickline ED, Du Y, Stolz DB, Kahn M, Monga SP. Neoplasia; 2013 Apr; 15(4):421-34. PubMed ID: 23555187 [Abstract] [Full Text] [Related]
28. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma. Sun Y, Mi W, Cai J, Ying W, Liu F, Lu H, Qiao Y, Jia W, Bi X, Lu N, Liu S, Qian X, Zhao X. J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787 [Abstract] [Full Text] [Related]
29. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis. Sera T, Hiasa Y, Mashiba T, Tokumoto Y, Hirooka M, Konishi I, Matsuura B, Michitaka K, Udaka K, Onji M. Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279 [Abstract] [Full Text] [Related]
30. Keratin 8 modulation of desmoplakin deposition at desmosomes in hepatocytes. Loranger A, Gilbert S, Brouard JS, Magin TM, Marceau N. Exp Cell Res; 2006 Dec 10; 312(20):4108-19. PubMed ID: 17126832 [Abstract] [Full Text] [Related]
31. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK. J Pathol; 2009 Aug 10; 218(4):520-9. PubMed ID: 19431154 [Abstract] [Full Text] [Related]
32. Involvement of RhoA in progression of human hepatocellular carcinoma. Wang D, Dou K, Xiang H, Song Z, Zhao Q, Chen Y, Li Y. J Gastroenterol Hepatol; 2007 Nov 10; 22(11):1916-20. PubMed ID: 17914970 [Abstract] [Full Text] [Related]
33. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Nassar A, Cohen C, Siddiqui MT. Diagn Cytopathol; 2009 Sep 10; 37(9):629-35. PubMed ID: 19405109 [Abstract] [Full Text] [Related]
34. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. Li W, Gomez E, Zhang Z. J Exp Clin Cancer Res; 2007 Dec 10; 26(4):527-33. PubMed ID: 18365549 [Abstract] [Full Text] [Related]
35. Heterogeneous nuclear ribonucleoproteins F and H/H' show differential expression in normal and selected cancer tissues. Honoré B, Baandrup U, Vorum H. Exp Cell Res; 2004 Mar 10; 294(1):199-209. PubMed ID: 14980514 [Abstract] [Full Text] [Related]
36. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study. Fujii T, Zen Y, Harada K, Niwa H, Masuda S, Kaizaki Y, Watanabe K, Kawashima A, Nakanuma Y. Hum Pathol; 2008 Aug 10; 39(8):1185-96. PubMed ID: 18547618 [Abstract] [Full Text] [Related]
37. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Lu Y, Wu LQ, Li CS, Wang SG, Han B. Hepatobiliary Pancreat Dis Int; 2008 Apr 10; 7(2):174-8. PubMed ID: 18397854 [Abstract] [Full Text] [Related]
38. Vascular density and VEGF expression in hepatic lesions. Brodsky SV, Mendelev N, Melamed M, Ramaswamy G. J Gastrointestin Liver Dis; 2007 Dec 10; 16(4):373-7. PubMed ID: 18193117 [Abstract] [Full Text] [Related]
39. Significance of the relationship between irregular regeneration and two hepatocarcinogenic pathways: "de novo" and so-called "dysplastic nodule-hepatocellular carcinoma" sequence. Taguchi K, Aishima S, Matsuura S, Terashi T, Nishiyama K, Shirabe K, Shimada M, Maehara Y, Tsuneyoshi M. J Surg Oncol; 2005 Nov 01; 92(2):100-3. PubMed ID: 16231367 [Abstract] [Full Text] [Related]
40. Bone marrow cells: the source of hepatocellular carcinoma? Wu XZ, Yu XH. Med Hypotheses; 2007 Nov 01; 69(1):36-42. PubMed ID: 17300877 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]